Patent · US Active

4-aminopiperidine derivatives

US7683079B2 · kind B2 · utility

1Cited by

9References

11Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Markus Boehringer
Daniel Hunziker
Bernd Kuhn · Sursee, CH
Bernd Loeffler · Oberrimsingen, DE
Thomas Luebbers · Soest, DE
Fabienne Ricklin · Hombourg, FR

Key dates

Filing date	Dec 14, 2005
Grant date	Mar 23, 2010
Priority date	—
Expiry date	Feb 25, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D277/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the formula (I)wherein R1 and R2 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, non-insulin dependent diabetes mellitus and/or impaired glucose tolerance, obesity, and/or metabolic syndrome or β-cell protection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.